Screening policy changes and prostate cancer epidemiology: 20-year trends in diagnosis, treatment, incidence, and mortality - PubMed
3 hours ago
- #Health Policy Impact
- #Cancer Epidemiology
- #Prostate Cancer Screening
- The study examines the impact of the 2012 and 2018 USPSTF PSA screening recommendations on U.S. prostate cancer trends over 20 years.
- Following the 2012 recommendation, overall age-standardized incidence fell by 20.6%, while distant-stage (metastatic) disease incidence rose by 9.3%, with a partial stabilization after 2018.
- Age-standardized mortality rates continued to decline but slowed from 2012 to 2017, then accelerated post-2018.
- Treatment patterns shifted from radical interventions toward conservative management, like active surveillance, especially among older men.
- Black men and residents of the Southern U.S. experienced the highest burden and most pronounced changes in incidence and mortality trends.
- The findings suggest reduced overdiagnosis but increased metastatic presentations, highlighting a need for precision diagnostics, risk-adapted screening, and equity-focused implementation to reduce disparities.